Rohan Palekar - 08 Jun 2023 Form 4 Insider Report for Neoleukin Therapeutics, Inc. (NLTX)

Role
Director
Signature
/s/ Sean Smith, Attorney-in-Fact for Rohan Palekar
Issuer symbol
NLTX
Transactions as of
08 Jun 2023
Transactions value $
$0
Form type
4
Filing time
09 Jun 2023, 16:27:28 UTC
Previous filing
07 Jun 2023
Next filing
05 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NLTX Stock Option (Right to Buy) Award $0 +25K $0.00 25K 08 Jun 2023 Common Stock 25K $0.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/12 of the total shares monthly beginning July 8, 2023 until the option is fully vested on June 8, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.